Prot #ITM-LET-01: A Prospective, Randomised, Controlled, Open-label, Multicentre Phase III Study to Evaluate Efficacy and Safety of Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu-Edotreotide Compared to Targeted Molecular Therapy with Everolimus

Project: Research project

Project Details

StatusFinished
Effective start/end date2/24/21 → 2/24/24

Funding

  • PSI Pharma Support America Inc. ((OE) Prot #ITM-LET-01 // (OE) Prot #ITM-LET-01)
  • ITM Solucin GmbH ((OE) Prot #ITM-LET-01 // (OE) Prot #ITM-LET-01)